CME Group jumps after Q2 earnings beat and strong trading activity

CME Group (CME) is up 7% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied primarily to a better-than-expected second-quarter earnings report and management highlighting the strongest first half in the company’s history. Investors also seem to be responding to strong trading activity, record market data revenue, and continued evidence that volatility and hedging demand are supporting the exchange operator’s core business.

Details:

CME Group posted second-quarter adjusted earnings of $2.99 per share on revenue of about $1.7 billion, with profitability aided by solid trading and clearing activity.

Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted earnings per share.

Second-quarter average daily volume reached 29.8 million contracts, marking one of the company’s strongest quarters, while non-U.S. average daily volume was 9.1 million contracts.

Market data revenue hit a record $238 million in the quarter, and June average daily volume had already climbed 19% year over year, suggesting momentum was in place before the earnings release.

Sources:

CME Group, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CME Insider Trading Activity

$CME insiders have traded $CME stock on the open market 13 times in the past 6 months. Of those trades, 4 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:

TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 35,000 shares for an estimated $10,447,865.
HILDA HARRIS PIELL (Sr MD & Chief HR Officer) sold 5,753 shares for an estimated $1,752,536
KEN VROMAN (Chief Transformation Officer) sold 5,160 shares for an estimated $1,594,440
BRYAN T DURKIN sold 4,200 shares for an estimated $1,300,530
JONATHAN L MARCUS (Sr MD General Counsel) sold 3,291 shares for an estimated $1,097,120
WILLIAM R SHEPARD has made 4 purchases buying 1,808 shares for an estimated $515,287 and 0 sales.
ELIZABETH A COOK sold 1,000 shares for an estimated $320,000
DENNIS SUSKIND sold 748 shares for an estimated $224,400
MARTIN J GEPSMAN sold 300 shares for an estimated $91,770

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CME Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CME Hedge Fund Activity

We have seen 765 institutional investors add shares of $CME stock to their portfolio, and 746 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ALPHABET INC. added 3,484,020 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,041,547,779
CAPITAL RESEARCH GLOBAL INVESTORS added 2,272,083 shares (+213.9%) to their portfolio in Q1 2026, for an estimated $679,239,212
PRICE T ROWE ASSOCIATES INC /MD/ removed 2,074,465 shares (-30.1%) from their portfolio in Q1 2026, for an estimated $620,161,311
EGERTON CAPITAL (UK) LLP removed 1,182,907 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $261,221,352
BANK OF AMERICA CORP /DE/ added 1,130,587 shares (+39.1%) to their portfolio in Q1 2026, for an estimated $337,988,983
TWO SIGMA INVESTMENTS, LP added 1,111,993 shares (+2817.7%) to their portfolio in Q1 2026, for an estimated $332,430,307
MORGAN STANLEY added 1,043,692 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $312,011,723

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CME Congressional Stock Trading

Members of Congress have traded $CME stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 06/16.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CME Price Targets

Multiple analysts have issued price targets for $CME recently. We have seen 10 analysts offer price targets for $CME in the last 6 months, with a median target of $312.5.

Here are some recent targets:

Benjamin Budish from Barclays set a target price of $270.0 on 07/09/2026
Alex Kramm from UBS set a target price of $260.0 on 07/06/2026
Patrick O'Shaughnessy from Raymond James set a target price of $320.0 on 07/02/2026
Chris Allen from Keefe, Bruyette & Woods set a target price of $305.0 on 06/18/2026
Simon Clinch from Rothschild & Co set a target price of $323.0 on 06/11/2026
Michael Cyprys from Morgan Stanley set a target price of $353.0 on 04/23/2026
Patrick Moley from Piper Sandler set a target price of $329.0 on 04/15/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.